Developing an industrial artemisinic acid fermentation process to support the cost‐effective production of antimalarial artemisinin‐based combination therapies
Authors:
Open Access
- 17 September 2008
- journal article
- research article
- Published by Wiley in Biotechnology Progress
- Vol. 24 (5) , 1026-1032
Abstract
Artemisinin‐based combination therapies (ACTs) are currently unaffordable for many of the people who need them most. A major cost component of ACTs is the plant‐derived artemisinin. A fermentation process for a precursor to artemisinin might provide a viable second source to stabilize the artemisinin supply and therefore reduce price. The heterologous production of artemisinic acid, an artemisinin precursor, by Saccharomyces cerevisiae was improved 25‐fold from a 100 mg/L flask process to a 2.5 g/L process in bioreactors. A defined medium fed‐batch process with galactose as the carbon source and inducer was developed, with titers of 1.3 g/L. In this strain ERG9 was controlled with promoter Pmet3 so that methionine repressed the sterol biosynthesis pathway and increased precursor availability for artemisinic acid biosynthesis. Addition of methionine to the process increased artemisinic acid titers to 1.8 g/L. A dissolved oxygen‐stat algorithm was developed, which simultaneously controlled the agitation and feed pump. This improved process control and increased titers to 2.5 g/L.Keywords
This publication has 13 references indexed in Scilit:
- Engineering of the pyruvate dehydrogenase bypass in Saccharomyces cerevisiae for high-level production of isoprenoidsMetabolic Engineering, 2007
- High‐level production of amorpha‐4,11‐diene in a two‐phase partitioning bioreactor of metabolically engineered Escherichia coliBiotechnology and Bioengineering, 2006
- Production of the antimalarial drug precursor artemisinic acid in engineered yeastNature, 2006
- Production of the Artemisinin Precursor Amorpha-4,11-diene by Engineered Saccharomyces cerevisiaeBiotechnology Letters, 2006
- Source of New Hope Against Malaria is in Short SupplyScience, 2005
- Production of lipid compounds in the yeast Saccharomyces cerevisiaeApplied Microbiology and Biotechnology, 2003
- Toward consistent and productive complex media for industrial fermentations: Studies on yeast extract for a recombinant yeast fermentation processBiotechnology and Bioengineering, 2003
- Malaria disaster in AfricaThe Lancet, 1998
- Recombinant Protein Expression in High Cell Density Fed-Batch Cultures of Escherichia ColiNature Biotechnology, 1992
- Controlled expression and purification of human immune interferon from high‐cell‐density fermentations of Saccharomyces cerevisiaeBiotechnology and Bioengineering, 1987